Journal of Biomedical and Translational Research

Research and Publication Ethics

1. The objectives of these regulations were to prohibit the production of scientific papers by unethical animal experimentation or unethical writing on the J Biomed Transl Res.

2. Research Ethics Committee are composed of 5 members of which three can be appointed among the editors by a president of the Research Institute of Veterinary Medicine (RIVM). The president of RIVM and Editor-in-Chief of J Biomed Transl Res will be deserved for the members.

3. Research Ethics Committee shall perform the following tasks.

(1) To ascertain activities of animal experimentation ethics committee in research institutes for ethical animal experiments.
(2) To encourage compliance with ethical procedures of animal experiments
(3) To advertise research ethics for the submitter and promote their submission to the journal
(4) To review compliance with ethical animal experiments and fair procedures in submitted papers
(5) To discipline members violating ethics rules

4. As a scientific paper including results from animal experiments submitted to the J Biomed Transl Res, the manuscript must be submitted according to the following regulations.

(1) Animal experiments should be described to insert the phrase in the manuscript according to what ethical guidelines have been made.
(2) When judges of the Committee request the ethics review process to an animal experimentation ethics committee of institutions (Institutional Animal Care and Use Committee, IACUC) or a head (or head of department), an approval of the proposed guidelines should be submitted.

5. A corresponding author or first author who wants to submit a manuscript to the J Biomed Transl Res should guarantee that the followings are not subject to any protest.

(1) Dual publication, dual display or segmented publishing
(2) Plagiarism or scientific imitation
(3) Fake or fabrication

6. Selection and Description of Participants

Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex and/or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex and gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.

(1) Authorship
The J Biomed Transl Res follows the recommendations for authorship by the International Committee of Medical Journal Editors (ICMJE) 2019 (http://www.icmje.org/icmje-recommendations.pdf). Authorship credit should be based on 1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; 2) Drafting the work or revising it critically for important intellectual content; 3) Final approval of the version to be published; and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions of 1, 2, 3, and 4. In addition, an author should be accountable for the parts of the work he or she has done and should be able to identify which co-authors are responsible for specific other parts of the work. Authors should have confidence in the integrity of the contributions of their coauthors. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged as contributors not be authors. These authorship criteria are intended to reserve the status of authorship for those who deserve credit and can take responsibility for the work.
The criteria are not intended for use as a means to disqualify colleagues from authorship who otherwise meet authorship criteria by denying them the opportunity to meet criterion #2 or 3. Therefore, all individuals who meet the first criterion should have the opportunity to participate in the review, drafting, and final approval of the manuscript.
(2) Conflict of interest
The corresponding author of an article is asked to inform the Editor of the authors’ potential conflicts of interest possibly influencing the research or interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may include financial support or private connections, political pressure from interest groups, or academic problems. Disclosure form shall be same with ICMJE Uniform Disclosure Form for Potential Conflicts of Interest (http://www.icmje.org/coi_disclosure.pdf). The Editor will decide whether the information on the conflict should be included in the published paper. In particular, all sources of funding for a study should be explicitly stated. The conflicts of interest may occur during the research process as well; however, it is important to provide disclosure. If there is a disclosure, editors, reviewers, and reader can approach the manuscript after understanding the situation and the background of the completed research.

8. A corresponding or first author who does not comply with Animal Experimentation Ethics or Ethics to write a paper will take the following sanctions.

(1) When judges request relevant evidence to a corresponding or first author who does not abide by Section 4/Subsection 1, a manuscript will be turned down before review process if an approval of the proposed guidelines has not been made or submitted as described in the Section 4/Subsection 2.
(2) If a corresponding or first author is proved to submit a fake of animal ethics approval or false documents to the Committee as described in the Section 4/Subsection 2, he (she) will be prohibited to submit a manuscript to the J Biomed Transl Res for 3 years.
(3) A corresponding or first author who violates any one of the Subsections described in the Section 5, he (she) will be prohibited to submit a manuscript to the J Biomed Transl Res for 3 years commencing a decision date.
(4) If a corresponding or first author is subject to sanctions more than two times as described in the Section 5, he (she) will receive a lifetime ban from the J Biomed Transl Res.
For the policies on the research and publication ethics not stated in this instruction, “Committee on Publication Ethics Guidelines(https://publicationethics.org/guidance/Guidelines)” can be applied.